rTMS and Body Shape Perception (STIMOREX)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Anorexia nervosa (AN) is a frequent, potentially life-threatening eating disorder characterized by a resistance to maintaining body weight at or above a minimally normal weight for age and height, an intense fear of weight gain or being "fat" even though underweight, a loss of menstrual periods in girls and women post-puberty and a disturbance in the experience of body weight or shape. Body weight and shape dissatisfaction is linked to the development, maintenance and relapse of AN. Neuroimaging studies have shown that the inferior parietal cortex is involved in body image perception and less activated in patients with AN compared with healthy subjects. Repetitive transcranial magnetic stimulation (rTMS) is used to modulate cortical excitability, and particularly to increase excitability with high-frequency rTMS. The aim of this study was to investigate the effect of "excitatory" high-frequency rTMS over the "hypoactive" inferior parietal cortex of 54 patients with AN.
This randomized, double-blind, placebo-controlled study will compare effective rTMS (2000 ten-Hz stimulations per session, applied at 90% of the resting motor threshold, with 10 sessions in two weeks) versus placebo rTMS.
Assessments will be performed before rTMS and after the last rTMS session (immediately after, at 15 days and three months). The principal criteria for judgement is a body image satisfaction scale (Boby Shape Questionnaire, BSQ-34). The secondary criteria for judgement are eating behaviour scales (Eating Attitude Test, EAT-40; Bulimia test, BULIT and Eating Disorders Inventory, EDI-2), the Hamilton depression rating scale and Hamilton anxiety rating scale, a quality of life scale (Short-Form Health Survey, SF-36), a body composition analysis using a Dual-energy X-ray absorptiometry and the alpha-MSH autoantibodies levels (biomarker for eating disorders recently described).
Inferior parietal cortex rTMS could not only improve body image perception, but also help in the treatment of eating disorders, allowing weight gain with a decreased anxiety and improving patients' quality of life. Also positive results could have direct therapeutic implications with the possibility to complete regular rTMS sessions, or to implant extradural electrodes for chronic parietal cortex stimulation.
| Condition | Intervention |
|---|---|
|
Anorexia Nervosa |
Procedure: Sham rTMS Procedure: rTMS |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Effect of Transcranial Magnetic Stimulation on Disturbance of Body Shape Perception in Patients With Anorexia Nervosa |
- BSQ-34 scale (Body Shape Questionnaire) [ Time Frame: Just after rTMS ] [ Designated as safety issue: No ]
- EAT-40 scale (eating attitude test) [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- BULIT scale (bulimia test) [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- EDI-2 scale (eating disorder inventory) [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- Hamilton scale [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMSBefore rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- Quality of Life Scale, MOS 36 Item Short-Form Health Survey or SF-36 [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- The body mass index [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- body composition analysis using dual energy X-ray absorptiometry [ Time Frame: Before rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- autoantibodies against alpha-melanocyte stimulating hormone [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- The adverse effects [ Time Frame: After rTMS ] [ Designated as safety issue: Yes ]
- Weight [ Time Frame: Before rTMS, just after rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
- BSQ-34 scale (Body Shape Questionnaire) [ Time Frame: Before rTMS, 15 days after rTMS and 3 months after rTMS ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 54 |
| Study Start Date: | October 2012 |
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | October 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Effective arm
Effective coil
|
Procedure: rTMS
120 pulses 0.2Hz
|
|
Placebo Comparator: Placebo arm
Placebo coil
|
Procedure: Sham rTMS
120 pulses 0.2Hz
|
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Female
- Age above 18
- Restrictive anorexia nervosa with a disease duration more than one year and less than three years.
- Body Mass Index below 16
- Patient receiving or having received optimal treatment for anorexia nervosa
- Right-handed
- Normal blood ionogramme
- Previous stable antidepressor treatment for one month and no expected modification in the three following months
- Patients arriving by car with someone else or by public transportation
Exclusion Criteria:
- Pregnancy
- Contraindication to transcranial magnetic stimulation i.e. pace-maker, cardiac valve protheses, metallic protheses etc.
- History of epileptic seizure
- Cerebral lesion of any etiology (post-traumatic, tumoral, vascular etc.)
- History of previous rTMS
Contacts and Locations
More Information
No publications provided
| Responsible Party: | University Hospital, Rouen |
| ClinicalTrials.gov Identifier: | NCT01717079 History of Changes |
| Other Study ID Numbers: | 2011/122/HP |
| Study First Received: | September 24, 2012 |
| Last Updated: | October 29, 2012 |
| Health Authority: | France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis) |
Additional relevant MeSH terms:
|
Anorexia Anorexia Nervosa Signs and Symptoms, Digestive |
Signs and Symptoms Eating Disorders Mental Disorders |
ClinicalTrials.gov processed this record on May 22, 2013